Search

everythinglearnresearchcommunity

for

Search:↓

HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Monoclonal antibodies are often linked to alopecia areata cases.

RHUPUS should be considered in children with deforming arthritis.

JAK inhibitors show promise in treating difficult skin diseases.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Abatacept may help some people with alopecia areata regrow hair.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Emulgels effectively deliver hydrophobic drugs for skin conditions like acne and psoriasis.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Omalizumab may cause hair loss.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.